President Donald Trump signed an executive order on Saturday aimed at beefing up research of psychedelic drugs like ibogaine that could be used in mental health treatments. Some veterans and people who have struggled with addiction who have used ibogaine say this could be a breakthrough that could lead to wider access, but some medical experts are warning approvals shouldn’t be rushed. We hear why a leading advocate group says while it’s a good start – much more has to be done. 

For more: Trump accelerates research on psychedelic treatments and asks, ‘Can I have some?’ 

--- 

Guests: Samantha Juan & Melissa Lavasani, Psychedelic Medicine Coalition Founder/CEO 

Host: David Rind 

Producer: Paola Ortiz 

Showrunner: Felicia Patinkin 

Editorial Support: Katherine Dillinger

Photo: Jim Watson/AFP/Getty Images

Learn more about your ad choices. Visit podcastchoices.com/adchoices